SAN DIEGO — The Food and Drug Administration has approved a new opioid analgesic but not without controversy. In approving Zohydro ER (hydrocodone bitartrate extended-release capsules), the FDA went against an 11-2 recommendation by a panel of outside experts to… Read More
SUNNYVALE, CA — For the first time, the Food and Drug Administration is allowing marketing of a device to relieve pain caused by migraine headaches that are preceded by an aura. The device, the Cerena Transcranial Magnetic Stimulator (TMS), is… Read More
WASHINGTON — A new sodium-glucose co-transporter 2 (SGLT2) inhibitor has been approved to treat type 2 diabetes. The Food and Drug Administration approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults. Farxiga is marketed… Read More
WASHINGTON — Use of novel anticoagulants has risen sharply both at the VA and in the Army in the last three years, freeing more atrial fibrillation patients from food restrictions and regular checks for coagulation time, as required when using warfarin.
DENVER — Personalized attention from a pharmacist increases medication adherence in patients to nearly 90% in the year following hospitalization for acute coronary syndrome (ACS), according to a recent study.